Evidence map›Paper›PMID 18757073›Full record

ArticleVirology2008

Cellular serine/threonine phosphatase activity during human cytomegalovirus infection.

Morgan Hakki, Adam P Geballe

Open access · greenAbstract read
In one paragraph

Article in Virology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.6field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Morgan HakkiDivisions of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA. mhakki@fhcrc.org
Adam P Geballe
Fred Hutch Cancer Center · US

Funding

TRANSLATIONAL CONTROL OF CYTOMEGALOVIRUS GENE EXPRESSIONR01AI026672 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI GEBALLE, ADAM P. · 1994 to 2017
$6.9M
Double-Stranded RNA Binding Proteins of CytomegalovirusK08AI058089 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI HAKKI, MORGAN B · 2004 to 2008
$593k
NIAID NIH HHS K08 AI058089NIAID NIH HHS R01 AI026672NIAID NIH HHS R01 AI26672
6 · The paper itself

Abstract

While the importance of cellular and viral kinases in HCMV replication has been demonstrated, relatively little is known about the activity of cellular phosphatases. We conducted a series of experiments designed to investigate the effect of HCMV infection on cellular serine/threonine phosphatase activity. We found that the abundance of two major cellular serine/threonine phosphatases, PP1 and PP2A, increases during HCMV infection. This was associated with an increase in threonine phosphatase activity in HCMV-infected cells. HCMV infection conferred resistance to the effects of the phosphatase inhibitors calyculin A (CA) and okadaic acid with regards to global protein hyperphosphorylation and the shutoff of protein synthesis. The protective effect of HCMV infection could be overcome at a high concentration of CA, suggesting that cellular phosphatase activity is required for critical cellular processes during HCMV infection. Specifically, phosphatase activity was required to limit the accumulation of phospho-eIF2alpha, but not phospho-PKR, during HCMV infection.

Indexed as

Cytomegalovirus InfectionsAnimalsCells, CulturedeIF-2 KinaseEnzyme InhibitorsEukaryotic Initiation Factor-2HumansMarine ToxinsMiceOkadaic AcidOxazolesPhosphoprotein PhosphatasesPhosphorylationProtein Biosynthesiscalyculin AeIF-2 KinaseEnzyme InhibitorsEukaryotic Initiation Factor-2Marine ToxinsOkadaic AcidOxazolesPhosphoprotein Phosphatases

Identifiers

PMID18757073
PMCPMC2654193
OpenAlexW2070728713

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.